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Received 23 May 2007; received in revised form 22 October 2007; accepted 13 November 2007AbstractThe objective of this study was to compare the in vitro fermentability of xylo-oligosaccharides (XOS) with different degrees of polymeri-
sation (DP) by the intestinal digesta collected in three distinct intestinal sections of the porcine intestinal tract: ileum, caecum, and distal colon.
The studied oligosaccharides included commercial short-chain XOS (DP 2e5), and medium-chain (DP 2e14) and long-chain (DP 2e25) XOS
obtained by autohydrolysis of brewery’s spent grain (BSG), corn cobs (CC) and Eucalyptus globulus wood (EUC). The oligosaccharide and
monosaccharide consumption, lactate and short-chain fatty acids concentrations were correlated with shifts on PCR titres of Bacteroides/
Prevotella, Bifidobacterium and Lactobacillus/Pediococcus populations, by using group- and genus-specific primers.
All tested XOS were extensively fermented by the piglet ileal, caecal and colonic microbiota. The rate of consumption of medium- and long-
chain XOS was notably reduced in the fermentations by the ileal inoculum as compared to commercial XOS. EUC XOS, CC XOS and com-
mercial XOS supported an enhancement of bifidobacteria and lactobacilli replication in a first stage of the fermentations. Apparently this
stimulation was not selective, because Bacteroides/Prevotella replication increased in a second stage of the fermentations, coincident in time
with the highest consumption rates of some XOS mixtures tested. Mostly due to the slow fermentability by the ileal microbiota, medium-chain
and long-chain XOS mixtures can be regarded as promising functional candidates suitable to act as distally fermentable substrates.
 2007 Swiss Society of Food Science and Technology. Published by Elsevier Ltd. All rights reserved.
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The prebiotic properties of some non-digestible oligosaccha-
rides (NDO) and polysaccharides, namely fructo-oligosaccharides
(FOS), transgalacto-oligosaccharides (TGOS) and inulin, have
been extensively studied and there is great evidence of the
physiological effects and health consequences of their con-
sumption (Gibson, McCartney, & Rastall, 2005; Pool-Zobel,
2005; Watzl, Girrbach, & Roller, 2006). Other oligosaccha-
rides (OS), such as xylo-oligosaccharides (XOS), isomalto-
oligosaccharides (IMOS) and soy-oligosaccharides (SOS) are* Corresponding author. Tel.: þ351 210924600; fax: þ351 217163636.
E-mail address: paula.esteves@ineti.pt (M.P. Esteves).
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doi:10.1016/j.lwt.2007.11.007classified as ‘‘emerging prebiotics’’, presenting a promising
prebiotic potential although they still lack of strong scientific
evidence (Gibson, Probert, Van Loo, Rastall, & Roberfroid,
2004; Tuohy, Rouzaud, Bruck, & Gibson, 2005).
Okazaki, Fujikawa, and Matsumoto (1990) were pioneers
in the study of the prebiotic effects of XOS. These authors ob-
served a significant but transient increase in bifidobacterial
numbers and organic acids levels in the faeces of human vol-
unteers consuming short-chain XOS. Similar bifidogenic ef-
fects were described in rats and mice consuming XOS, more
notably in animals presenting lower initial bifidobacterial
numbers (Campbell, Fahey, & Wolf, 1997; Morishita, Yamada,
Shiiba, Kimura, & Taniguchi, 1993). XOS-dependent bifido-
bacterial up-shifts observed in vivo are consistently supportedhed by Elsevier Ltd. All rights reserved.
1953P. Moura et al. / LWT - Food Science and Technology 41 (2008) 1952e1961by in vitro studies (Crittenden et al., 2002; Jaskari et al., 1998;
Moura, Barata, et al., 2007; Palframan, Gibson, & Rastall,
2003). However, the evidence for a selective stimulation of
bifidobacterial growth by XOS has not been demonstrated. Mi-
croorganisms belonging to Bacteroides, Clostridium and Lac-
tobacillus genera are also able to metabolise XOS mixtures
mainly composed by xylobiose and xylotriose (Crittenden
et al., 2002; Van Laere, Hartemink, Bosveld, Schols, & Vora-
gen, 2000). However, more complex XOS structures have pre-
sented a higher capability to be selectivity fermented by
bifidobacteria (Van Laere et al., 2000).
XOS can be produced by autohydrolysis of xylan-rich ma-
terials, such as byproducts from agricultural, agro-industrial
and forestry origin (Garrote, Domı́nguez, & Parajó, 1999a;
Garrote, Domı́nguez, & Parajó, 1999b). The process promotes
hydrolysis of the hemicellulosic fraction of lignocellulosic
materials and, although it consists of a non-selective fraction-
ation process, the operational conditions can be optimised for
XOS production. Chemically, XOS produced by autohydroly-
sis are constituted by a b-(1 / 4)-D-xylopyranose backbone
which can be more or less substituted, depending on the feed-
stock material and the severity of the hydrothermal treatment
(Carvalheiro, Garrote, Parajó, Pereira, & Gı́rio et al., 2005;
Ebringerová, Hromádková, & Heinze, 2005). The crude
XOS hydrolysates can be separated by gel filtration chroma-
tography (GFC), and selected fractions can be pooled to obtain
a desired average molecular weight range. This possibility en-
ables the preparation of XOS mixtures with increased molec-
ular weight, theoretically more capable to persist throughout
the gastrointestinal (GI) tract and to support a saccharolytic
fermentation up to more distal compartments of the intestinal
tract when compared to short-chain XOS (Rastall & Maitin,
2002; van de Wiele, Boon, Possemiers, Jacobs, & Verstraete,
2007).
As NDO with promising prebiotic potential, XOS produced
by autohydrolysis may constitute a dietary alternative to anti-
microbial growth promoters, whose inclusion in animal diets
has recently been banned in Europe (Patterson, 2005). In
this study, we conducted a comparative study on the ferment-
ability of commercial short-chain XOS and longer-chain XOS
obtained by autohydrolysis. Our aim was to identify differ-
ences which could be of relevance concerning XOS prebiotic
potential and its use as feed supplements.
2. Material and methods2.1. Feedstock materials and preparation of purified
XOS seriesChips of E. globulus wood (EUC) were obtained from
ENCE Complejo Industrial de Pontevedra, Puentemolinos,
Lourizan (Spain). Corn cobs (CC) and brewery’s spent grain
(BSG) were supplied by Casa Agrı́cola Monte Real, Salvaterra
de Magos (Portugal) and Sociedade Central de Cervejas, Via-
longa (Portugal), respectively. Crude XOS-rich hydrolysates
of CC, obtained as previously described (Garrote et al.,
1999b) were received from J.C. Parajó (University of Vigo,Ourense, Spain). Crude de-starched XOS-rich hydrolysates
of BSG were obtained from F. Carvalheiro (Carvalheiro, Es-
teves, Parajó, Pereira, & Gı́rio, 2004). Gram-quantities of
purified XOS series (DP 2e25) from EUC crude hydrolysates,
prepared as described by Kabel, Schols, and Voragen (2002),
were received from H. Schols (Wageningen University, Wage-
ningen, the Netherlands).
CC and BSG XOS-rich hydrolysates were purified and char-
acterized as described by Moura, Barata, et al. (2007). Briefly,
the liquid phases obtained from the autohydrolysis treatments
were pooled together for separation of xylo-oligosaccharides
(XOS) in a preparative gel filtration chromatography (GFC) col-
umn BPG 100/950 (Amersham Pharmacia Biotech, Uppsala,
Sweden) filled with Superdex 30. The system was equipped
with a refractive index detector (K-2401 Knauer, Berlin,
Germany). Separated fractions were collected into plastic
bottles using a Super-frac collector (Amersham Pharmacia
Biotech) and characterised in terms of apparent molar mass in
a LaChrom HPLC system (Merck, Darmstadt, Germany) equip-
ped with three in-series size exclusion chromatography col-
umns BIOSEP-SEC (Phenomenex, Torrance, USA), S4000,
S3000 and S2000, using 50 mM NaNO3 as eluent at 30
C,
and a RI detector (Merck L-7490). Calibration was performed
with external standards of xylose, maltose, maltotriose, sta-
chyose and dextrans (Sigma, St. Louis, USA) with molecular
weights ranging from 1000 to 580,000 Da. Calibration was
used to delimit the ranges of the GFC fractions of CC XOS
and BSG XOS to be pooled together. The BSG XOS and CC
XOS pools had an estimated apparent molar mass ranging
from 1760 to 429 Da and 2160 to 286 Da, respectively, that cor-
respond to average degrees of polymerisation (DP) from 12 to 3,
and 14 to 2, respectively. The pools were freeze-dried (Lab-
conco, Kansas City, USA) prior to the use in the fermentation
assays. The Kjeldahl method was used to determine the nitrogen
content of BSG XOS and the conversion factor of 5.83 (AOAC
Official Methods of Analysis, 1975; FAO, 2002) was used to
express the equivalent amount of protein.2.2. Mono- and oligosaccharide composition
of the XOS mixturesThe purified XOS series obtained from EUC, CC and BSG
autohydrolysis and commercial XOS (Suntory Ltd., Osaka, Ja-
pan) were analysed by HPLC for quantitative carbohydrate
analysis. The HPLC system (Waters, Milford, USA) was equip-
ped with an Aminex HPX-87H column (Bio-Rad, Hercules,
USA) in combination with a cation Hþ-guard column (Bio-
Rad) and a refractive index detector (Waters 2410). Elution
took place at 50 C with 5 mM H2SO4. OS were quantified by
quantitative acid hydrolysis (QAH) of the selected XOS series
with 40 g/kg of H2SO4 at 121
C for 60 min. OS concentrations
were expressed as the increase in sugar monomers after QAH.2.3. Intestinal samplesIntestinal samples were obtained from one healthy 34-day-
old Duroc Landrace male piglet, fed with a commercial
1954 P. Moura et al. / LWT - Food Science and Technology 41 (2008) 1952e1961weaning diet based on barley and soybean meal. The animal
was sacrificed after a 16 h fasting period for removal of the en-
tire GI tract. Samples from the luminal contents of the termi-
nal ileum, caecum and distal colon were collected into sterile
vials. All vials were kept refrigerated until arrival to the labo-
ratory and preparation of the intestinal inocula for the fermen-
tation assays did not exceed 2 h after collection.2.4. Fermentation mediaThe nutrient base medium used in the fermentation exper-
iments was modified from Jaskari et al. (1998) and prepared
as described previously (Moura, Barata, et al., 2007) except
that a 100 mM solution of sodium hydroxide was used as sol-
vent. The medium was deoxygenated with nitrogen and carbon
dioxide using a gassing manifold system and pH was adjusted
to 6.8. Nine-milliliter aliquots were distributed into airtight an-
aerobic culture tubes (Bellco Biotechnology Inc., Vineland,
USA), which were capped with butyl rubber stoppers and
sealed with aluminium caps (Bellco Biotechnology Inc.) be-
fore autoclave sterilisation. Anaerobic stock solutions of Yeast
Nitrogen Base (YNB) (Difco, Detroit, Michigan, USA) and
XOS were prepared in airtight serum bottles and distributed
into the culture tubes, to final concentrations of 5.0 g/L of
freeze-dried powder.2.5. Fermentation experimentThe inocula for the fermentation experiments were pre-
pared as described by Moura, Barata, et al. (2007). Briefly,
the intestinal contents were diluted in reduced physiological
saline (RPS), pH 6.8 (Hartemink, 1999) before inoculation.
The tubes with the fermentation medium were inoculated
with 0.2 mL of each intestinal dilution, in duplicate (CC
XOS) or triplicate (EUC, BSG and commercial XOS) for
each combination of inocula/sampling time (0, 11.5, 30 and
72 h), and incubated at 37 C for 72 h. At each sampling
time, cells were harvested by centrifugation and supernatants
were filtered for HPLC analysis.2.6. DNA isolation and PCRNucleoSpin Tissue Kit (Mackerey-Nagel, Düren, Germany)
was used to isolate DNA of cells harvested from the fermen-
tation experiments. Total DNA was serially diluted starting
from 10 ng (correspondent to 1/1 dil.), to be used as templateTable 1
Genus- and group-specific primers used in this study






BactrF2 ACin PCR reactions. The primers used in this study are presented
in Table 1. Amplification reactions with Lactobacillus group-
specific primers were performed according to the optimized
protocol previously described for FOS fermentations (Moura,
Sim~oes, Gı́rio, Loureiro-Dias, & Esteves, 2007). Bifidobacte-
rium genus-specific primers were used according to Matsuki
et al. (2002) and Bacteroides/Prevotella specific primers
according to Menaia, Sim~oes, Sousa, Moura, and Amaral-
Collaço (1998). Electrophoresis was performed on 1% agarose
gels in 1 TAE buffer, and each lane was loaded with a fixed
volume of sample. PCR products were visualised using ethid-
ium bromide staining.2.7. Quantification of carbohydrates and fermentation
products in the fermentation supernatantsThe filtered supernatants from the culture tubes were ana-
lysed for carbohydrates and main fermentation products (lac-
tate, acetate, propionate and butyrate) by HPLC with an
Aminex HPX-87H column (Bio-Rad, Richmond, USA)
against external standards, as described above.
3. Results & discussion3.1. Characterisation of the XOS mixturesXOS produced by autohydrolysis derived from three differ-
ent xylan-rich feedstock materials, namely E. globulus wood,
corn cobs and brewery’s spent grain. The total content in
oligo- and monosaccharides of each XOS mixture is presented
in Table 2. The composition of each XOS series is primarily
determined by the xylan source used in the autohydrolysis
treatments. Considering that some feedstocks used for autohy-
drolysis derived from arabinoxylan-rich materials, the amount
of XOS in the mixtures was calculated considering the sum of
xylose and arabinose equivalents released by QAH, and xy-
lose-based OS were uniformly referred to as XOS. The glu-
cose released after QAH possibly deriving from glucan of
the feedstock materials was referred to as glucose oligomers
(GlcOS).
The XOS selected for this study corresponded to mixtures
with three different ranges of DP. Commercial XOS compris-
ing mainly xylobiose and xylotriose can be classified as short-
chain XOS. The XOS series up to DP 14 from corn cobs
(CC XOS) and from brewery’s spent grain (BSG XOS) can
be referred to as medium-chain XOS. XOS mixtures frommer sequence (50 to 30) Source or reference
CCATGTGTAGCGGTG Heilig et al. (2002)
AAAACTAAACAAAGTTTC Moura, Sim~oes, et al. (2007)
CCTGGAAACGGGTGG Matsuki et al. (2002)
TGTTCTTCCCGATATCTACA Matsuki et al. (2002)
GGTTCTGAGAGGAAG Menaia et al. (1998)
CCCCCATTGTAACAC Menaia et al. (1998)
Table 2
Characterisation of the XOS mixtures used in the fermentations by piglet in-
testinal inocula. Oligomeric carbohydrates were determined as monomeric
equivalents released after QAH
EUC XOS CC XOS BSG XOS Commercial XOS
DP range 2e25 2e14 3e12 2e5
XOSa 807 709 411 833
GlcOSa 30 57 90 58
Glucosea 7 ND ND 10
Xylosea 9 16 11 5
Arabinosea ND 19 4 ND
Othersa 147 199 484 94
Ara/Xylb 0 2 20 11
AcO/Xylb 43 20 12 1
UA/Xylb nd nd nd nd
ND, not detected; nd, not determined; EUC XOS, xylo-oligosaccharides pro-
duced from E. globulus wood; CC XOS, xylo-oligosaccharides produced from
corn cobs; BSG XOS, xylo-oligosaccharides produced from brewery’s spent
grain; DP, degree of polymerisation; GlcOS, glucose oligomers; Ara, arabi-
nose; Xyl, Xylose; AcO, acetyl substituents; UA, uronic acids.
a g/kg dry weight.
b mol/100 mol e molar percentage of released arabinose or acetic acid per
released xylose, after QAH.
1955P. Moura et al. / LWT - Food Science and Technology 41 (2008) 1952e1961Eucalyptus wood (EUC XOS) comprising molecules up to DP
25 can be designated as long-chain XOS. The IUB-IUPAC no-
menclature defines oligosaccharides as saccharides containing
between 2 and 10 sugar moieties (IUB-IUPAC, 1982), al-
though molecules with a molecular range up to 19 monosac-
charide units can be considered as NDO (Voragen, 1998).
Under a nutritional point of view, oligomeric structures with
DP up to 50 can be defined as resistant short-chain carbohy-
drates (RSCC), which cannot be hydrolysed by mammalian
endogenous enzymes of the small intestine (Englyst & Eng-
lyst, 2005). According to this later definition, all XOS mix-
tures from Table 2 can be classified as RSCC and therefore
constitute potential fermentation substrates at the hindgut
level.
Because BSG is known by its high protein content (Santos,
Jiménez, Bartolomé, Gómez-Cordovés, & del Nozal, 2003),
the nitrogen content of BSG XOS was determined (48 g/kg),
which corresponds to 278 g/kg (dry weight basis) when ex-
pressed as protein equivalents. Apparently, the fractionation
step included in the present work was not efficient enough
to purify BSG XOS (Table 2) and it can be speculated that hy-
drolysis products from BSG proteins were still included in the
selected pool of BSG XOS. Among all the mixtures produced
by autohydrolysis, only BSG XOS presented a considerable
value for GlcOS (Table 2).3.2. Consumption of OS and accumulation of lactate
and SCFA in the fermentation mediaThe concentrations of XOS, free monosaccharides and
SCFA in the fermentation media were monitored for 72 h
(Fig. 1), so as GlcOS concentration of the BSG XOS mixture
(Fig. 2). The amount of each OS mixture added to the culture
media was standardised on the basis of dry weight of freeze-
dried product (5 g/L), which introduced slight differences onmono- and oligosaccharides content in the culture media.
The pH values did not decrease markedly during the 72 h of
the fermentation trials (final pH 6.5).
In vitro experiments allow the comparison of rates to which
OS are broken down and consumed in fermentation experi-
ments. Therefore, these experiments are important to deter-
mine quantifiable parameters suitable for comparing the
in vitro fermentability of the different substrates. The decline
of XOS concentration in the growth media and the increase in
organic acids throughout the fermentations were indicative of
extensive microbial fermentation by all the inocula (Fig. 1).
No accumulation of monosaccharides occurred as conse-
quence of OS disappearance in the media (Fig. 1). The major
differences on XOS consumption profiles occurred on XOS
produced by autohydrolysis between the fermentations by
the ileal and the large intestine inocula. In the fermentations
by the ileal inoculum, the consumption profiles of medium-
and long-chain XOS were similar throughout all fermenta-
tions. After 30 h, averagely 76% of the initial amount of these
XOS remained in the media as fermentation substrate. After-
wards the concentrations slowly decreased up to 72 h. In the
fermentations by the caecal or colonic inocula, medium- and
long-chain XOS were all utilised to a similar extent (<15% re-
sidual) up to 30 h. The highest consumption rates by the caecal
or colonic inocula of EUC XOS were determined between
11.5 and 30 h, whereas CC XOS and BSG XOS originated
an almost constant consumption rate from 0 up to 30 h. Re-
garding the contribution of GlcOS of the BSG XOS mixture
(Table 2), 84.2, 86.6 and 86.9% of the initial GlcOS were con-
sumed by the microorganisms from, respectively, the ileal,
caecal and colonic inocula up to 11.5 h. In opposition to auto-
hydrolysis XOS, commercial XOS were rapidly consumed by
the ileal microbiota, remaining in the medium only 25% of the
initial amount after 30 h. Interestingly, the consumption pat-
tern of commercial XOS by the inocula from the large intes-
tine displayed a trend to resist an initial degradation up to
11.5 h resembled to that of EUC XOS. The slower fermenta-
tion rate of EUC XOS, CC XOS and BSG XOS by the ileal
inoculum denotes a lower fermentation efficiency of the fore-
gut microbiota towards longer molecules of XOS, when com-
pared to short-chain XOS. In this study it was not possible to
find a correlation between the rate of XOS consumption and
their degree of substitution by arabinose or acetyl groups. In
order to fulfil the prebiotic criteria (Gibson et al., 2004)
XOS need to resist hydrolysis by the microbiota from the up-
per part of the piglet GI tract. Consequently, the slower fer-
mentability of EUC XOS, CC XOS and BSG XOS by the
ileal digesta may indicate their adequacy as more persistent
OS, potentially capable of reaching more distal compartments
of the porcine GI tract. In a previous study, a series of chem-
ically diverse oligosaccharides including short-chain XOS
were compared in their in vitro fermentability by porcine fae-
cal digesta (Smiricky-Tjardes et al., 2003). The slow rate to
which short-chain XOS were fermented led the authors to sug-
gest that such XOS would constitute a suitable source of fer-
mentable substrate for the distal portion of the pig GI tract.
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Fig. 1. Consumption of XOS and SCFA accumulation during 72 h of in vitro fermentation of XOS mixtures from Eucalyptus wood (EUC XOS), corn cobs
(CC XOS), brewery’s spent grain (BSG XOS) and commercial XOS by the ileal, caecal and colonic inocula. (B XOS, 6 SCFA, free monosaccharides;
Ileum; Caecum; C Colon; Ileum; Caecum; : Colon; Ileum; Caecum; Colon).
1956 P. Moura et al. / LWT - Food Science and Technology 41 (2008) 1952e1961rapidly consumed than EUC XOS, CC XOS or BSG XOS by
the ileal digesta. Comparing the consumption profiles, it is
possible to advocate an even greater capability of the latter
XOS to persist throughout the porcine GI tract.
In vitro methods are also valuable to measure the produc-
tion of organic acids since these are not absorbed or metabo-
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Fig. 2. Consumption of glucose oligomers (GlcOS) during 72 h of in vitro fer-
mentation of XOS mixtures from brewery’s spent grain (BSG XOS) by the il-
eal, caecal and colonic inocula. ( Ileum; Caecum; Colon).piglet digesta collected in different gut compartments, not only
the extent of XOS fermentation, but also the type and relative
amounts of organic acids produced can be compared. Major
SCFA resulting from fermentation in mammalian intestinal
tract are acetate, propionate and butyrate, whereas lactate is
an intermediate metabolite from the fermentation process
(Macfarlane & Macfarlane, 2003). The amounts of these or-
ganic acids accumulated during in vitro fermentation of all
the XOS mixtures are represented in Fig. 3. The inocula
from the caecum and colon fermented XOS faster (more rapid
accumulation of SCFA) and to a greater extent (greatest SCFA
accumulation) than the ileal inoculum (Fig. 3). Lactate was
typically detected in low concentrations in a first stage of
the fermentations. In the fermentations by the ileal inoculum,
lactate was detected up to 30 h, although increases from 11.5
to 30 h were only registered for commercial XOS and CC
XOS. Lactate production at the beginning of the experiments
is in accordance with the fact that it is an intermediary product
of carbohydrate fermentation which can be converted to ace-
tate, propionate and butyrate by common intestinal bacteria
(Belenguer et al., 2006; Cotta & Whitehead, 1998; Duncan,
Louis, & Flint, 2004). Lactate production can be correlated
with the involvement of lactic bacteria and bifidobacteria early
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Fig. 3. Accumulation of SCFA and lactate during 72 h of in vitro fermentation of XOS mixtures from Eucalyptus wood (EUC XOS), corn cobs (CC XOS),
brewery’s spent grain (BSG XOS) and commercial XOS by the ileal, caecal and colonic inocula. (- Lactate, , Acetate, F Propionate, Butyrate).
1957P. Moura et al. / LWT - Food Science and Technology 41 (2008) 1952e1961(Crittenden et al., 2002) producing lactate and acetate but not
butyrate (Scardovi, 1988). Strains of Selenomonas ruminan-
tium are also described as able to ferment XOS not only to lac-
tate and acetate, but also producing propionate (Cotta &
Whitehead, 1998). Members of this genus were reported to
be present in the colonic wall and in the stomach of pigs (Mik-
kelsen, Højberg, & Jensen, 2007; Pryde, Richardson, Stewart,
& Flint, 1999). In general, it was observed that propionate
concentrations tended to stabilise up to 30 h or to decrease
slightly afterwards. Acetate and butyrate were the major fer-
mentation end-products in all cases; the former was detected
in all sampling times, whereas butyrate only started to accu-
mulate after 11.5 h. XOS acetogenic potential observed in
this study is in agreement with previous data from in vitro fer-
mentations of commercial XOS using pig faecal contents and
in vivo experiments with rats fed with diets supplemented with
commercial XOS (Imaizumi, Nakatsu, Sato, Sedarnawati, &Sugano, 1991; Smiricky-Tjardes et al., 2003). In the fermenta-
tions by the caecal and colonic inocula, the concentrations of
both acetate and butyrate increased more rapidly, between
11.5 and 30 h. In the fermentations of EUC XOS and CC
XOS by the ileal inoculum, acetate concentrations increased
later, from 30 to 72 h, while butyrate concentrations suffered
major increases from 30 to 72 h in all cases.
Exploring the differences between XOS mixtures, the con-
centrations of acetate and lactate after 30 h were considerably
higher for commercial XOS than for any other XOS mixture in
the fermentations by the ileal inoculum, suggesting a correla-
tion with the rapid consumption of short-chain XOS observed
from 11.5 to 30 h (Fig. 1). In a second stage of commercial
XOS fermentation by the ileal digesta (>30 h), in which XOS
were 25% residual in the fermentation media, butyrate accumu-
lated up to a higher concentration as compared to all the other
XOS. A better temporal correspondence was observed between
1958 P. Moura et al. / LWT - Food Science and Technology 41 (2008) 1952e1961medium- and long-chain XOS consumption and butyrate pro-
duction, suggesting the possibility of longer XOS to act as
butyrogenic substrates. Butyrate arising from microbial fer-
mentation is important for the energy metabolism and normal
development of colonic epithelial cells and presents an impor-
tant protective role in relation to colonic disease (Pryde, Dun-
can, Hold, Stewart, & Flint, 2002). However, the former
assumption is in disagreement with results obtained in fermen-
tations of medium-chain XOS by human faecal inocula, where
butyrate was mainly produced when all XOS were already de-
graded (Kabel, Kortenoeven, Schols, & Voragen, 2002). Some
authors refer that the butyrogenic effect of certain dietary sub-
strates can be explained by lactate cross-feeding between
genera capable of fermenting oligo- or polysaccharides, which
are lactate-producers, and genera capable of utilising lactate,
which are butyrate-producers (Belenguer et al., 2006; Duncan
et al., 2004). Accordingly, considering that lactate reached
a considerable concentration (13.0 mmol/L) in the fermenta-
tion of commercial XOS by the ileal inoculum during the first
30 h, it is expected that substantial lactate fermentation to bu-
tyrate has occurred. Since a rapid fermentation rate of lactate
to butyrate and/or acetate may turn lactate undetectable, it is
not possible to rule out the same hypothesis for the other fer-
mentations of this study. Similar observations have already
been registered in controlled co-cultures of lactate-producers
and lactate-utilisers/butyrate-producers using starch as carbo-
hydrate energy source (Duncan et al., 2004).
Considering the contribution of GlcOS in the mixture from
BSG autohydrolysis and the fact that it was considerably con-
sumed up to 11.5 h (Fig. 2), some differences could be ex-
pected in the fermentation products accumulated in the
media during the same time period. In the fermentations by
the colonic digesta, acetate and propionate concentrations
were slightly higher at 11.5 h as compared to other XOS and
very small amounts of butyrate were already detected up to
11.5 h in the fermentations by the caecal and colonic inocula.3.3. PCR titresThe Lactobacillus/Pediococcus and Bacteroides/Prevotella
group-specific and Bifidobacterium genus-specific primer pairs
listed in Table 1 were used to determine the maximum dilution
of total DNA able to produce PCR amplification (PCR titre).
The PCR titres determined throughout XOS fermentations
by the ileal, caecal and colonic inocula are presented in
Fig. 4. Considering that the PCR titre corresponds to a detec-
tion limit (Wang, Cao, & Cerniglia, 1996) which depends on
the proportion of targeted DNA among total DNA, it should
allow to monitor shifts of targeted bacterial groups in mixed
culture fermentations. The aim of determining PCR titres was
to compare the efficacy of the different XOS mixtures to sup-
port the replication of bifidobacteria and lactobacilli, more spe-
cifically to evaluate XOS potential to act as selective substrate
and/or to affect the targeted bacterial groups differently depend-
ing on the GI section from which each inocula was collected.
The PCR titres obtained with Lab0677Fþ Lact71R attained
considerable values at the beginning of the fermentations.Except for BSG XOS, increases of the PCR titres with
Lab0677Fþ Lact71R were only noticed from 0 up to 11.5 h
for all the inocula. In the fermentations by the ileal inoculum,
commercial XOS supported the major increase with the former
primer pair. After 11.5 h, the PCR titres produced with
Lab0677Fþ Lact71R and the ileal inoculum in the fermenta-
tions of commercial XOS decreased steadily up to 72 h. This
decrease was less pronounced for CC XOS and the value of the
PCR titre of EUC XOS at 30 h was maintained up to 72 h. In
the fermentations by the caecal inoculum, increases in the
PCR titres produced with Lab0677Fþ Lact71R were more
pronounced for commercial XOS and EUC XOS. BSG XOS
gave rise to the Lactobacillus/Pediococcus profile presenting
the lowest increase from 0 up to 11.5 h in the fermentations
by caecal inoculum. The maximal PCR titres from Lactobacil-
lus/Pediococcus detection were attained up to 11.5 h in the fer-
mentations of commercial XOS by the inoculum from the
colon. Bifidobacteria were not detected in any sample at 0 h.
However, increases in the PCR titres determined at 11.5 h in
the fermentations of EUC XOS, CC XOS and commercial
XOS by the ileal inoculum denoted that bifidobacterial repli-
cation was stimulated in a first stage of fermentation. BSG
XOS were unable to raise notably bifidobacterial PCR titres
in the fermentations by the ileal inoculum. In the fermenta-
tions by the caecal inoculum, the PCR titre profiles obtained
with Bifid-Fþ Bifid-R showed an increase up to 11.5 h on
EUC XOS and BSG XOS, and up to 30 h on CC XOS. Sur-
prisingly, commercial XOS were unable to produce a notable
increase on bifidobacterial detection limit in the fermentations
by microorganisms from the caecum. The most consistent in-
creases on Bifidobacterium PCR titres in the fermentations by
the colonic inoculum were obtained for commercial XOS and
CC XOS. In these cases, PCR titres increased from 0 to 11.5 h,
more notably for commercial XOS than for CC XOS, and the
values were maintained up to 30 h for CC XOS and up to 72 h
for commercial XOS. According to the results of the PCR ti-
tres (Fig. 4), the replication of Bifidobacterium and Lactobacil-
lus/Pediococcus was enhanced at the beginning of the
fermentations, in most cases up to 11.5 h. Lactic acid bacteria
are common inhabitants of the porcine GI tract (Jensen, 2001).
Lactobacillus/Enterococcus constitute a stable population
along the porcine intestinal tract (Franklin, Mathew, Vickers,
& Clift, 2002; Mountzouris et al., 2006) which is in agreement
with the PCR titres obtained with Lab0677Fþ Lact71R at the
beginning of the fermentations. Irrespective of the inocula, the
XOS with the highest impact (highest increase on the detec-
tion limit) on Lactobacillus/Pediococcus replication were
commercial XOS. Particularly in the fermentations of
commercial XOS by the ileal inoculum, increases on
Lab0677Fþ Lact71R PCR titres were concomitant with the
highest lactate concentrations up to 30 h (Fig. 3) which agrees
with the proportional relevance of lactobacilli in the proximal
intestinal regions of the porcine GI tract (Jensen, 2001). In op-
position to lactic acid bacteria, bifidobacteria represent a minor
proportion of the intestinal microbiota in the porcine GI tract
(Mikkelsen, Bendixen, Jakobsen, & Jensen, 2003), which is in
accordance with no amplification produced by PCR with the
EUC XOS
CC  XOS 
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Fig. 4. Log10 values of the maximal dilutions of total DNA (isolated at 0, 11.5, 30 and 72 h from XOS fermentations by the ileal, caecal and colonic inocula)
capable of producing the expected amplicon by PCR using the primer pairs Lab0677Fþ Lact71R, Bifid-FþBifid-R or BactrF1þBactrF2. Values were based
in duplicates of independent positive PCR reactions, and values for 0 h were averaged for the respective inoculum and primer pair. (- Ileum, , Caecum,
Colon).
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quent increases on the PCR titres obtained with this primer
pair indicate that bifidobacteria were able to replicate up to de-
tectable levels in the first stage of most XOS fermentations.
Commercial XOS demonstrated the highest efficacy (highest
increase on the detection limit and subsequent maintenance
of a detectable level of bifidobacteria) in stimulating bifido-
bacterial replication in the fermentation by the colonic inocu-
lum, immediately followed by CC XOS. The preference of
bifidobacteria to utilise short-chain XOS in vitro has already
been described (Crittenden et al., 2002). In vivo, the bifido-
genic character of short-chain XOS has been reported in hu-
mans and rats (Campbell, Fahey, & Wolf, 1997; Hsu, Liao,
Chung, Hsieh, & Chan, 2004; Okazaki et al., 1990). This bifi-
dogenic potential of XOS is a promising characteristic in pig
nutrition since it is general consensus that the effect is in-
versely related to the initial bifidobacterial counts of human
volunteers or animals (Morishita et al., 1993; Van Loo et al.,
1999). In spite of the diverse DP, EUC XOS, CC XOS and
commercial XOS originated similar profiles of enhancementof bifidobacterial replication in the fermentations by the ileal
inoculum (Fig. 4), and EUC XOS was able to maintain the bi-
fidobacterial detection level further up to 72 h denoting some
temporal coincidence with the respective consumption profile
(Fig. 1). The maintenance of Bifidobacterium PCR titres at
considerable detection levels up to 72 h in the case of EUC
XOS (ileal digesta) and commercial XOS (colonic digesta)
suggests that this bacterial group was able to attain a consider-
able representation throughout the fermentations, which is
a desirable characteristic regarding XOS prebiotic potential.
The replication of Bacteroides/Prevotella occurred typi-
cally in a second stage of fermentation. In the fermentations
by the ileal inoculum, PCR titres were inexpressive at 0 h
but the values increased markedly from 11.5 to 30 h in all
cases. The values were maintained or increased up to 72 h
and were higher for XOS produced by autohydrolysis than
for commercial XOS. With the caecal inoculum, Bacter-
oides/Prevotella PCR titres increased progressively up to
30 h in the fermentations of EUC XOS. Comparatively, this
increase occurred only up to 11.5 h on commercial XOS.
1960 P. Moura et al. / LWT - Food Science and Technology 41 (2008) 1952e1961CC XOS reached the highest BactrF1þ BactrF2 PCR titre at
30 h, whereas BSG XOS maximum was detected at 72 h. In
the fermentations of commercial XOS and EUC XOS by the
colonic inoculum the detection level of Bacteroides/Prevotella
increased steadily up to 30 h and maintained the value up to
72 h. CC XOS produced a similar detection pattern except
that the maximum PCR titre was only attained in the samples
from 72 h. BSG XOS seemed unable to enhance replication of
Bacteroides/Prevotella in the fermentations by colonic micro-
organisms. In order to compose some hypothesis concerning
XOS capability to selectively stimulate the replication of ben-
eficial bacteria it would be of utmost importance the establish-
ment of a clear correlation between PCR up-shifts observed
for Bifidobacterium and Lactobacillus/Pediococcus popula-
tions and XOS consumption profiles. Except in the fermenta-
tion of CC XOS by the colonic digesta, this correlation was
not possible to set since the replication of these bacterial
groups was mainly enhanced during the first 11.5 h. In fact,
it was easier to identify a temporal coincidence between the
highest XOS consumption rates and increases in PCR titres
of Bacteroides/Prevotella populations than of bifidobacteria
or lactobacilli, even for the ileal inoculum. Bacteroides strains
are described as able to utilise commercial XOS (Crittenden
et al., 2002). Consequently, the suggestion that medium- and
long-chain XOS are not selective for bifidobacterial and/or
lactobacilli growth would be consensual with previous obser-
vations for short-chain XOS. Considering that Bacteroides/
Prevotella replication occurs mainly in a second stage of fer-
mentation, it is not possible from this study to evaluate
whether growth can be a direct result of XOS hydrolysis and
uptake or of cross-feeding of intermediate substrates resulting
from OS breakdown (Belenguer et al., 2006) or even from in-
termediate fermentation of lactate, as discussed above. More
complete studies involving carbon flow analysis in controlled
co-cultures would be necessary to enlighten these issues.
4. Conclusions
From this study, it can be concluded that XOS produced by
autohydrolysis with a DP range up to 25 can be fermented
in vitro by the ileal, caecal and colonic microbiota of a
Duroc Landrace piglet. The longer chain length of the XOS
mixtures produced by autohydrolysis reduced notably the rate
of XOS consumption in the fermentations by the microbiota
from the piglet’s ileum. EUC XOS, CC XOS and commercial
XOS supported an enhancement of bifidobacteria and lacto-
bacilli replication in a first stage of fermentation, up to
11.5 h. Apparently this stimulation was not selective, because
Bacteroides/Prevotella replication increased in a second stage
of fermentation, coincident in time with the highest consump-
tion rates of some XOS mixtures tested. Mostly due to the
slow fermentability by the ileal inocula, EUC XOS, CC XOS
and BSG XOS can be regarded as promising functional candi-
dates suitable to act as distally fermentable substrates. Amongst
the mixtures produced by autohydrolysis, EUC XOS and CC
XOS appeared to be more promising than BSG XOS in stimu-
lating bifidobacteria and lactobacilli replication in vitro.Acknowledgments
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